ARIA
Library/neuroprotection/Neurotensin Fragment (NT69L)

Neurotensin Fragment (NT69L)

Not FDA Approved✓ WADA Permitted
neuroprotectionExperimentalNeurotensin analog

Synthetic fragment of neurotensin — a 13-amino acid neurotransmitter. Modulates dopamine signaling, has neuroprotective properties, and regulates intestinal motility. Research applications in neurodegenerative diseases and neuropsychiatric conditions.

Confidence
32%
Half-Life ~30 minutes
Quick Reference
Routeintranasal / subcutaneous
MechanismBinds to neurotensin receptors (NTS1, NTS2) → modulates dopamine signaling, prov...
Reviewed2026-06-08

Mechanism of Action

Binds to neurotensin receptors (NTS1, NTS2) → modulates dopamine signaling, provides neuroprotection, and regulates gut-brain axis via intestinal receptors. Crosses blood-brain barrier when administered intranasally.

Dosing Protocol

Research protocols: 100-500mcg intranasal daily. Not established for clinical supplementation.

Adverse Effects

Limited human dataPotential hypotensionNausea (intranasal)

Contraindications

  • Hypotension
  • Pregnancy
  • Psychiatric conditions (dopamine modulation)

Storage

Research use only.